Janus Henderson Investors
Active
London, United Kingdom
145
145M
122
20.71
7
0.15
57
- Areas of investment
Summary
In 2017 was created Janus Henderson Investors, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the London. The company was established in Europe in United Kingdom.
For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline BioNtech, Sojournix, Bigfoot Biomedical Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Machine Learning, Pharmaceutical.
We also calculated 11 valuable employees in our database.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The real fund results show that this Corporate Investor is 23 percentage points more often commits exit comparing to other companies.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Janus Henderson Investors, startups are often financed by Versant Ventures, Sectoral Asset Management, Jeffrey Brewer. The meaningful sponsors for the fund in investment in the same round are Cormorant Asset Management, Redmile Group, RA Capital Management. In the next rounds fund is usually obtained by Visionnaire Ventures, Silicon Valley Bank, Senvest Capital.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 145
- Lead investments
- 7
- Exits
- 57
- Rounds per year
- 20.71
- Follow on index
- 0.15
- Investments by industry
- Biotechnology (124)
- Health Care (74)
- Medical (50)
- Therapeutics (43)
- Life Science (32) Show 63 more
- Investments by region
-
- United States (124)
- Singapore (1)
- United Kingdom (4)
- Canada (3)
- China (2) Show 6 more
- Peak activity year
- 2021
- Number of Unicorns
- 7
- Number of Decacorns
- 8
- Number of Minotaurs
- 7
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 267M
- Group Appearance index
- 0.99
- Avg. company exit year
- 11
- Avg. multiplicator
- 1.72
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
IntelyCare | 06 Apr 2022 | Software, Health Care, Apps, Medical, Staffing Agency | Late Stage Venture | 115M | United States, Massachusetts, Quincy |
Lycia Therapeutics | 13 May 2024 | Biotechnology, Health Care, Life Science | Late Stage Venture | 106M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.